Please ensure Javascript is enabled for purposes of website accessibility
CASE REPORT
Can allergy affect the course of Lyme disease? A case report
 
More details
Hide details
1
Department of Family Medicine and Geriatrics, Institute of Medical Sciences, Faculty of Medicine and Health Science, Jan Kochanowski University, Kielce, Poland
 
2
Institute of Environmental Protection, National Research Institute, Warsaw, Poland
 
3
Laboratory of Psychology and Medical Pedagogy, Faculty of Medicine and Health Sciences, Institute of Public Health, Jan Kochanowski University, Kielce, Poland
 
4
Clinic of Internal Disease and Gastroenterology, Central Clinical Hospital Ministries of Internal Affairs and Administration Mental Health Clinic, Central Clinical Hospital Ministries of Internal Affairs and Administration, Warsaw, Poland
 
5
Cancer Marker Department, Świętokrzyskie Oncology Center, Kielce, Poland
 
 
Submission date: 2017-03-21
 
 
Final revision date: 2017-09-15
 
 
Acceptance date: 2017-10-27
 
 
Publication date: 2017-12-31
 
 
Medical Studies 2017;33(4):300-303
 
KEYWORDS
TOPICS
ABSTRACT
Sometimes other illnesses can complicate the course of allergic rhinitis, making it difficult to recognise or treat. An example of this type of connection is described in our case report of a patient with allergic rhinitis and concomitant Lyme disease. Aim of the study was to present the case of 54-year-old woman with a severe form of chronic allergic rhinitis, given the diagnosis of Lyme disease coexisting with inflammation of multiple joints. A 54-year-old patient with severe chronic allergic rhinitis, given the diagnosis of Lyme disease. Based on our description of the case, it appears that allergic inflammation from immunity in which a number of cytokines have been activated could be a factor favourable for launch by the spirochete Borrelia burgdorferi arthritis. Maybe the same immune disorders have led to the development of allergies contributing to such a course of Lyme disease and arthritis development.
REFERENCES (19)
1.
Bousquet J, Khaltaev N, Alvaro A. Alergiczny nieżyt nosa i jego wpływ na astmę. Alergia Astma Immunol 2008; Suppl 1: 57-82.
 
2.
Bobrowski M, Kuna P, Pietruczuk M. Rola chemokin w astmie. Diagn Labor 2011; 3: 323-330.
 
3.
Światowa strategia rozpoznawania, leczenia i prewencji astmy (GINA). Medycyna Praktyczna 2007; 1: 21-7.
 
4.
Durovska J, Bazovska S, Ondrisova M, Pancak J. Our experience with examination of antibodies against antigens of Borrelia burgdorferi in patients with suspected lyme disease. Bratisl Lek Listy 2010; 111: 153-155.
 
5.
Socan M, Blasko-Markic M, Erculj V, Lajovic J. Socio-economic characteristics in notified erythema migrans patients. Zdr Varst 2015; 54: 267-273.
 
6.
Bazovska S, Kondas M, Simkovicova M, Kmety E, Traubner P. Significance of specific antibody determination in Lyme borreliosis diagnosis. Bratisl Lek Listy 2001; 102: 454-457.
 
7.
Durovska J, Bazovska S, Pancak J, Zaborska M, Derdakova M, Traubner P. Infection with B. burgdorferi s.l., and CNS demyelinating disease. A case report. Neuro Endocrinol Lett 2011; 32: 411-414.
 
8.
Dzierzecka M, Kita J. The use of chosen serological diagnostic methods in Lyme disease in horses. Part I. Indirect immunofluorescence and enzyme-linked immunosorbent assay (ELISA). Pol J Vet Sci 2002; 5: 71-77.
 
9.
Seidelin JB, Rogler G, Nielsen OH. A role for interleukin-33 in T(H)2-polarized intestinal inflammation? Mucosal Immunol 2011; 4: 496-502.
 
10.
Nakae S, Morita H, Ohno T, Arae K, Matsumoto K, Saito H. Role of interleukin-33 in innate-type immune cells in allergy. Allergol Int 2013; 62: 13-20.
 
11.
Saluja R, Ketelaar ME, Hawro T, Church MK, Maurer M, Nawijn MC. The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders. Mol Immunol 2015; 63: 80-85.
 
12.
Rogala B, Gluck J. The role of interleukin-33 in rhinitis. Curr Allergy Asthma Rep 2013; 13: 196-202.
 
13.
Ohno T, Morita H, Arae K, Matsumoto K, Nakae S. Interleukin-33 in allergy. Allergy 2012; 67: 1203-1214.
 
14.
Szczepankiewicz A, Narożna B. Interleukiny w chorobach alergicznych – najnowsze odkrycia genetyczne. Alergia 2013; 4: 27-28.
 
15.
Śpiewak R. Contact eczema. Post Dermatol Alergol 2009; 26: 375-377.
 
16.
Mędrala W. Allergic contact eczema. In: The Elementary of Allergology. Mędrala W (ed.). Górnicki Medical Publisher House, Wrocław 2006; 271-278.
 
17.
Oosting M, van de Veerdonk FL, Kanneganti TD, Sturm P, Verschueren I, Berende A, van der Meer JW, Kullberg BJ, Netea MG, Joosten LA. Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism. Eur J Immunol 2011; 41: 172-181.
 
18.
Pei C, Barbour M, Fairlie-Clarke KJ, Allan D, Mu R, Jiang HR. Emerging role of interleukin-33 in autoimmune disease. Immunology 2014; 141: 9-17.
 
19.
Jura-Półtorak A, Olczyk K. Aktualne poglądy na etiopatogenezę reumatoidalnego zapalenia stawów. Ann Acad Med Silesien 2011; 65: 51-57.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top